https://generatebiomedicines.com/publications/ 2026-07-21T08:37:54+00:00 https://generatebiomedicines.com/publications/first-in-human-study-of-a-first-in-class-ai-designed-monoclonal-antibody-gb-0669-against-the-conserved-sars-cov-2-spike-s2-stem-helix/ 2026-06-25T21:19:05+00:00 https://generatebiomedicines.com/wp-content/uploads/2025/10/GB-0669-Image.png https://generatebiomedicines.com/publications/ers-2025-gb-0895-a-high-affinity-anti-tslp-mab-demonstrates-prolonged-half-life-and-sustained-pharmacological-activity-supporting-every-6-month-dosing-in-asthma/ 2026-06-25T21:26:45+00:00 https://generatebiomedicines.com/wp-content/uploads/2025/09/ERS-2025-GB-0895-Presentation.avif https://generatebiomedicines.com/wp-content/uploads/2025/09/ERS-2025-GB-0895-Presentation.avif https://generatebiomedicines.com/publications/ers-2025-eposter/ 2026-06-25T21:27:26+00:00 https://generatebiomedicines.com/wp-content/uploads/2025/09/ERS-2025-ePoster.avif https://generatebiomedicines.com/wp-content/uploads/2025/09/ERS-2025-ePoster.avif https://generatebiomedicines.com/publications/functional-and-structural-characterization-of-a-combination-of-pan-sarbecovirus-antibodies-with-potent-antiviral-activity/ 2026-06-25T21:31:32+00:00 https://generatebiomedicines.com/wp-content/uploads/2025/04/GB-0669-PRO-37587-Thumbnail.avif https://generatebiomedicines.com/publications/id-week-2024-preclinical/ 2026-06-25T21:34:07+00:00 https://generatebiomedicines.com/wp-content/uploads/2024/10/CleanShot-2024-11-13-at-16.26.35@2x.avif https://generatebiomedicines.com/publications/idweek-2024-ftih-presentation/ 2026-06-25T21:36:41+00:00 https://generatebiomedicines.com/wp-content/uploads/2024/10/CleanShot-2024-11-13-at-16.26.41@2x.avif https://generatebiomedicines.com/publications/illuminating-protein-space-with-a-programmable-generative-model-2/ 2026-06-25T21:44:16+00:00 https://generatebiomedicines.com/wp-content/uploads/2023/11/cover-default@2x.jpg https://generatebiomedicines.com/publications/protein-re-surfacing-of-e-coli-l-asparaginase-to-evade-pre-existing-anti-drug-antibodies-and-hypersensitivity-responses-2/ 2026-06-25T21:45:58+00:00 https://generatebiomedicines.com/wp-content/uploads/2023/11/cover-default@2x.jpg https://generatebiomedicines.com/publications/randomized-double-blind-placebo-controlled-first-in-human-trial-of-a-first-in-class-ai-designed-monoclonal-antibody-gb-0669-against-the-conserved-sars-cov-2-spike-s2-stem-helix/ 2026-07-21T08:37:54+00:00 https://generatebiomedicines.com/wp-content/uploads/2024/10/generate_bio_sars_GIF.00_00_18_18.Still003.avif